• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物-脂质药物纳米载体:新制剂与生产技术的创新

Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies.

作者信息

Bochicchio Sabrina, Lamberti Gaetano, Barba Anna Angela

机构信息

Eng4Life Srl, Spin-Off Accademico, Via Fiorentino, 32, 83100 Avellino, Italy.

Dipartimento di Ingegneria Industriale, Università Degli Studi di Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.

出版信息

Pharmaceutics. 2021 Feb 2;13(2):198. doi: 10.3390/pharmaceutics13020198.

DOI:10.3390/pharmaceutics13020198
PMID:33540659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7913085/
Abstract

Some issues in pharmaceutical therapies such as instability, poor membrane permeability, and bioavailability of drugs can be solved by the design of suitable delivery systems based on the combination of two pillar classes of ingredients: polymers and lipids. At the same time, modern technologies are required to overcome production limitations (low productivity, high energy consumption, expensive setup, long process times) to pass at the industrial level. In this paper, a summary of applications of polymeric and lipid materials combined as nanostructures (hybrid nanocarriers) is reported. Then, recent techniques adopted in the production of hybrid nanoparticles are discussed, highlighting limitations still present that hold back the industrial implementation.

摘要

药物治疗中的一些问题,如药物的不稳定性、较差的膜通透性和生物利用度,可以通过基于聚合物和脂质这两类主要成分组合设计合适的给药系统来解决。同时,需要现代技术来克服生产限制(低生产率、高能耗、昂贵的设备、较长的加工时间),以便达到工业生产水平。本文报道了聚合物和脂质材料组合形成纳米结构(混合纳米载体)的应用总结。然后,讨论了混合纳米颗粒生产中采用的最新技术,突出了仍然存在的阻碍工业应用的局限性。

相似文献

1
Polymer-Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies.聚合物-脂质药物纳米载体:新制剂与生产技术的创新
Pharmaceutics. 2021 Feb 2;13(2):198. doi: 10.3390/pharmaceutics13020198.
2
Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.聚合物-脂质杂化系统:融合聚合物基和脂质基纳米载体的优势以改善口服药物递送
Expert Opin Drug Deliv. 2016;13(5):691-707. doi: 10.1517/17425247.2016.1151872. Epub 2016 Feb 23.
3
An update on polymer-lipid hybrid systems for improving oral drug delivery.聚合物-脂质杂化系统在改善口服药物传递方面的最新进展。
Expert Opin Drug Deliv. 2019 May;16(5):507-524. doi: 10.1080/17425247.2019.1605353. Epub 2019 Apr 18.
4
Advances in Hybrid Vesicular-based Drug Delivery Systems: Improved Biocompatibility, Targeting, Therapeutic Efficacy and Pharmacokinetics of Anticancer Drugs.基于混合囊泡的药物传递系统的进展:提高抗癌药物的生物相容性、靶向性、治疗效果和药代动力学。
Curr Drug Metab. 2022;23(9):757-780. doi: 10.2174/1389200223666220627110049.
5
Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability.脂多糖纳米系统提高口服生物利用度。
AAPS PharmSciTech. 2021 Sep 30;22(7):242. doi: 10.1208/s12249-021-02124-5.
6
Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.用于递送癌症治疗药物的脂质-聚合物杂化纳米载体。
J Control Release. 2018 Feb 10;271:60-73. doi: 10.1016/j.jconrel.2017.12.016. Epub 2017 Dec 19.
7
Nanocarriers protecting toward an intestinal pre-uptake metabolism.纳米载体保护作用以阻止肠道预先吸收代谢。
Nanomedicine (Lond). 2017 Feb;12(3):255-269. doi: 10.2217/nnm-2016-0331. Epub 2017 Jan 17.
8
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.超越脂质体:用于难溶性/难渗透性药物传递的基于脂质的纳米结构的最新进展。
Prog Lipid Res. 2017 Oct;68:1-11. doi: 10.1016/j.plipres.2017.07.001. Epub 2017 Aug 1.
9
Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.采用混合聚合物和脂质构建块设计用于纳米级药物递送至癌症治疗的纳米载体。
Nanoscale. 2017 Jan 26;9(4):1334-1355. doi: 10.1039/c6nr08486a.
10
Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.脂质聚合物杂化物作为用于口服给药的纳米载体中的新兴工具。
Artif Cells Nanomed Biotechnol. 2016;44(1):334-49. doi: 10.3109/21691401.2014.951721. Epub 2014 Sep 19.

引用本文的文献

1
An Overview on Lipid Nanocapsules: Exploring the Role in Precision Cancer Treatment and Lymphatic Drug Distribution.脂质纳米胶囊概述:探索其在精准癌症治疗和淋巴药物递送中的作用
Adv Pharm Bull. 2025 Jun 1;15(2):248-267. doi: 10.34172/apb.025.45109. eCollection 2025 Jul.
2
A Review of Formulation Strategies for Cyclodextrin-Enhanced Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs).环糊精增强型固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)的制剂策略综述
Int J Mol Sci. 2025 Jul 6;26(13):6509. doi: 10.3390/ijms26136509.
3
Enrofloxacin‑silver composite nano-emulsion as a scalable synergetic antibacterial platform for accelerating infected wound healing.

本文引用的文献

1
Design and production of hybrid nanoparticles with polymeric-lipid shell-core structures: conventional and next-generation approaches.具有聚合物-脂质核壳结构的杂化纳米颗粒的设计与制备:传统方法与新一代方法
RSC Adv. 2018 Oct 9;8(60):34614-34624. doi: 10.1039/c8ra07069e. eCollection 2018 Oct 4.
2
Micronutrients encapsulation in enhanced nanoliposomal carriers by a novel preparative technology.通过一种新型制备技术将微量营养素包裹于增强型纳米脂质体载体中。
RSC Adv. 2019 Jun 25;9(34):19800-19812. doi: 10.1039/c9ra03022k. eCollection 2019 Jun 19.
3
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems.
恩诺沙星-银复合纳米乳液作为一种可扩展的协同抗菌平台,用于加速感染伤口愈合。
Int J Pharm X. 2025 Mar 25;9:100330. doi: 10.1016/j.ijpx.2025.100330. eCollection 2025 Jun.
4
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment.药物靶向、药物递送及纳米技术应用的进展:在癌症治疗中的治疗意义
Pharmaceutics. 2025 Jan 16;17(1):121. doi: 10.3390/pharmaceutics17010121.
5
Photopolymerizable robust lipids towards reliability and their applications.用于提高可靠性的可光聚合坚固脂质及其应用。
Biophys Rev. 2024 Aug 31;16(6):773-782. doi: 10.1007/s12551-024-01221-6. eCollection 2024 Dec.
6
Targeting the Molecules in EMT: A Potential Therapeutic Opportunity in Breast Cancer.靶向上皮-间质转化中的分子:乳腺癌的潜在治疗机会
Curr Mol Med. 2025;25(5):567-588. doi: 10.2174/0115665240310780240805114133.
7
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.纳米材料驱动的精准免疫调节:治疗干预的新范式
Cancers (Basel). 2024 May 27;16(11):2030. doi: 10.3390/cancers16112030.
8
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases.纳米材料辅助基因编辑和合成生物学优化肺部疾病治疗
J Nanobiotechnology. 2024 Jun 18;22(1):343. doi: 10.1186/s12951-024-02627-w.
9
Natural Food Resource Valorization by Microwave Technology: Purslane Stabilization by Dielectric Heating.微波技术实现天然食物资源增值:通过介电加热实现马齿苋的稳定化处理
Foods. 2023 Nov 24;12(23):4247. doi: 10.3390/foods12234247.
10
Membrane-Active Thermoresponsive Block Copolymers Containing a Diacylglycerol-Based Segment: RAFT Synthesis, Doxorubicin Encapsulation, and Evaluation of Cytotoxicity against Breast Cancer Cells.含二酰基甘油基段的膜活性温敏嵌段共聚物:RAFT 合成、阿霉素包封及对乳腺癌细胞的细胞毒性评价。
Biomacromolecules. 2023 Nov 13;24(11):4854-4868. doi: 10.1021/acs.biomac.3c00580. Epub 2023 Oct 16.
固体脂质纳米粒简述:当代药物递送系统的重要组成部分
RSC Adv. 2020 Jul 17;10(45):26777-26791. doi: 10.1039/d0ra03491f. eCollection 2020 Jul 15.
4
Physicochemical Factors That Influence the Biocompatibility of Cationic Liposomes and Their Ability to Deliver DNA to the Nuclei of Ovarian Cancer SK-OV-3 Cells.影响阳离子脂质体生物相容性及其将DNA递送至卵巢癌SK-OV-3细胞核能力的物理化学因素。
Materials (Basel). 2021 Jan 16;14(2):416. doi: 10.3390/ma14020416.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Nanoparticles Coated with Cell Membranes for Biomedical Applications.用于生物医学应用的细胞膜包覆纳米颗粒
Biology (Basel). 2020 Nov 18;9(11):406. doi: 10.3390/biology9110406.
7
Improved pharmacokinetic and biodistribution of 5-fluorouracil loaded biomimetic nanoerythrocytes decorated nanocarriers for liver cancer treatment.载 5-氟尿嘧啶仿生纳米红细胞修饰纳米载体用于肝癌治疗的药代动力学和生物分布改善。
Colloids Surf B Biointerfaces. 2021 Jan;197:111380. doi: 10.1016/j.colsurfb.2020.111380. Epub 2020 Oct 4.
8
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。
N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.
9
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.多功能和刺激响应型纳米载体用于靶向治疗递送。
Expert Opin Drug Deliv. 2021 Feb;18(2):205-227. doi: 10.1080/17425247.2021.1828339. Epub 2020 Oct 8.
10
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA.用于 mRNA 的具有改进转染效率的杂交生物聚合物和脂质纳米粒子。
Cells. 2020 Sep 5;9(9):2034. doi: 10.3390/cells9092034.